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IN a recently published paper (Guimaraes, Lamerton and Christensen, 1955)
pronounced pathological changes and increased incidence of neoplasms in mice
injected intravenously with thorotrast were reported. A detailed description was
given of the cytological and histological changes observed in the liver, lungs and
spleen. These findings were comparable in many ways with those of Johansen
(1955) who studied the late effects of thorotrast injection in rabbits, particularly
with regard to the malignant reticulo-endotheliomas observed in both species.
The work reported in the present paper comprises a histological study of the
tissues of thorotrast-injected and control mice sacrificed at regular intervals, in
an endeavour to learn something of the sequence of changes which culminate
in the production ofneoplasms, particularly those observed in the liver.
EXPERIMENTAL
Plan ofExperiment
Fifty Schofield mice were injected intravenously with 0.1 ml. thorotrast, of
a commercial preparation of recent manufacture, and divided into groups of
five animals. Four mice died soon after the injections and six more died at
different intervals during the experiment. With the exception of one mouse
which died nine months after the injection, none that diedprior to sacrifice showed
any gross lesion. Groups of animals were killed every month after the injection
up to the sixth month. After that time the animals were sacrificed every two
months. In the first five months five animals were killed on each occasion, in the
sixth and eighth months four animals, and in the tenth and twelfth months three
and four animals respectively. In all cases the same number of controls were
sacrificed simultaneously.
Sections were taken from liver, spleen, lungs, kidneys, adrenals and bone
marrow. The stains used were haematoxylin-eosin, Maximov and Feulgen with




In the liver the types of changes observed in the thorotrast-injected animals
were those described in detail in the earlier paper. The giant and distorted
nuclei with the spherical "inclusion" bodies were first observed in the thorotrast
animals four months after injection, and were seen fairly regularly in all injectedJ. P. GUIMARAES AND L. F. LAMERTON
mice after that time. The intensity of the changes was, however, extremely
variable, being marked in some animals and just discernible in a few others,
having no apparent relationship with the amount ofthorotrast present but show-
ing definite increase with time. Reticulo-endothelial proliferation, of the type
shown in Fig. 1, was significant from the sixth month onwards, but here again
in a few specimens was almost entirely negligible. Two injected animals showed
malignant reticulo-endotheliomas (Fig. 2(a), 2(b), 3(a) and 3(b). One of these
animals died at nine months and owing to post-mortem changes only the liver
could be examined histologically. The increased size of the spleen, however,
suggested that the tumour was already disseminated. The second reticulo-
endothelioma was found in the animal sacrificed twelve months after injection
and was still confined to the liver. Hepatomas were observed in five injected
animals, sacrificed at six months, eight months, ten months and twelve months
(2) after injection. In three of these animals the hepatomas were multiple.
Among the control animals two showed solitary hepatomas, at seven and
twelve months respectively, but no generalised liver changes were seen until
twelve months, when there were some cell changes and reticulo-endothelial
proliferation, rather pronounced in two specimens.
MacCardle and Congdon (1955) have recently claimed to have observed changes
in the mitochondria of hepatic cells of mice given 500 to 1200r of X-radiation.
We were unable to detect any change in the morphology or arrangement of the
mitochondria in the thorotrast-injected mice (Fig. 4 and 5). Depending on their
position in the lobule, the cells both of injected and control animals showed the
same pattern of globulated, filamentous and rod-like mitochondria. Some
fragmentation and vesiculation ofthe mitochondria were observed in both treated
and control animals. These appearances are probably related to metabolic and
ageing processes.
EXPLANATION OF PLATES.
FIG. 1. Pre-malignant reticulo-endothelioma proliferation in the liver (mouse killed at twelve
months after thorotrast injection) H. & E. X 80.
FIG. 2(a).-First stage of malignant reticulo-endothelioma, still confined to the liver. Liver
cell changes present (Mouse killed at twelve months after thorotrast injection.) H & E.
x 80.
FIG. 2(b).-Same animal as Fig. 2(a). Another part of the liver, showing disruption of the
sinusoid wall and of the trabecular arrangement. Atrophy of liver cells. H. & E. X 80.
FIG. 3(a). More advanced stage of malignant reticulo-endotheliomas (Mouse died at nine
months.) H. & E. X 80.
FIG. 3(b).-Same animalasFig. 3(a),showingovergrowth oftheliverparenchymabythetumnour
cells. H.&E. X 80.
FIG. 4.-Mitochondria in liver of normal animal. Stain-phosphotungstic acid haematoxylin.
X 500.
FIG. 5.-Mitochondria in liver of thorotrast-injected animal (mouse killed at twelve months
after injection). X 500.
FIG. 6.-Acid phosphatase distribution in liver of normal animal. Gomori's stain. X 360.
FIG. 7. Acid phosphatase distribution in liver ofthorotrast-injected animal. The large black
area is a deposit of thorotrast (Mouse killed at twelve months after injection.) Gomari's
stain. X 360.
FIG. 9.-Thorotrast aggregates in liver of animal killed at 2 months. H. & E. X 85.
FIG. 10.-Thorotrast aggregates in liver of animal killed at 12 months. H.& E. X 85.
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The hepatomas found in both injected and control animals show the usual
increased basophilia in the cytoplasm. The amount of basophilic substance in
the hepatic cells appeared not to be affected by the presence of thorotrast.
The distribution ofacid phosphatase in theliverfollowedthesamepatternboth
in control and injected animals (Fig. 6 and 7). Some degree offatty degeneration
was found in both groups of animals.
In order to study the mitotic activity of the tissues the two groups of animals
sacrificed at twelve months were given 0-1 mg. ofcolchicine six hours before death.
No differences were observed between injected and control animals, apart from
the fact that the mitotic index within the hepatomas in the two injected animals
was about twice that within the hepatoma in the control animal.
In none ofthe animals, injected or control, was connective tissue proliferation
or a picture of cirrhosis seen at any time.
Other tissues
In the lung the amount ofthorotrast seen was very small compared with liver
or spleen, and none ofthe large deposits observed in the previous experiment were
seen. Multiple lung adenomas of the type described in the previous paper
were found in eight of the injected animals, sacrificed at five months, six months
(2), eight months, ten months (2) and twelve months (2). In the control animals
four lung adenomas of the same type were found in animals sacrificed at
six months, ten months and twelve months (2).
The concentration of thorotrast seen in the spleen was comparable with that
in the liver. No changes were observed in this experiment in the spleen apart
from increased cellularity oftheredpulp in afewspecimens.
A very small amount of thorotrast was found in kidney and bone marrow,
but no damage was observed in these or other tissues examined.
Radiation dosage
The estimation of the radiation dosage received by any tissue containing
thorotrast aggregates is a formidable problem. The dose received will depend on:
(a) The "age " of the thorotrast, that is, the extent to which pure thorium
232 is accompanied by its disintegration products, particularly radiothorium
(Th228). This problem has been considered by Rundo (1955).
(b) The size of the thorotrast aggregates, which will determine the extent of
self-absorption ofthe emitted alpha particles. The size and number ofaggregates
willdetermine the degree ofnon-uniformity ofradiation dosethroughoutthetissue.
(c) The movement of thorotrast particles within the tissue.
Rotblat and Ward (1953) have taken account of factors(a) and (b) in their
autoradiographic studies of thorotrast aggregates in tissue specimens from
patients who had received thorotrast intravenously some years previously. On
the basis of the terminal distribution of the thorotrast aggregates they find
(personal communication) a mean value for the radiation dose in the liver ofabout
2 rep/week for an intravenous injection of 20 ml. of thorotrast. The value of 2
rep/week represents an average over the whole organ. In the immediate
neighbourhood ofthe aggregate the dose may be many times this value.
In the present mouse experiments it has not been possible to carry out detailed
autoradiographic studies of the type made by Rotblat and Ward (1953), but if
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one were to assume that the liver of the mouse took up the same fraction of the
injected material and that the size, distribution and "age" of the thorotrast
aggregates were the same as in the human case the mean dose to the liver would
be ofthe order of 20 rep/week since, on a body weight basis, the mice received ten
times as much as in the human case. This value can only be taken as giving an
order of magnitude for the terminal dosage rate since in the mouse experiments
the thorotrast used was of recent manufacture and at 12 months (when the last
group of mice was killed) the average size of the thorotrast aggregates was
probably considerably greater than in the human cases studied by Rotblat and
Ward (1953).
A study of the growth in size of the aggregates with time has been made in
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FIG. 8.-Number of thorotrast aggregates above 33,u mean linear dimensions in given area (4.7
mm.2) of 5p liver sections at various times after injection.
number of aggregates of mean linear dimensions greater than 33#t in a given area
(4.7 mm2) of a 5#t section of liver, for sections taken at 1, 2 . . . 12 months
after injection. Each point represents counts on a separate slide and, although
there is considerable scatter, the increase with time in the number of large
aggregates is very evident. Thus there was a considerable movement of thoro-
trast within the mouse liver tissue, at least up to 12 months after injection. The
consequence of this is that the liver tissue will receive a much more uniform
radiation dose than would be expected on the basis only of the terminal distribu-
tion of the aggregates, which may explain why the cytological changes observed
in the sections are not seen only in the neighbourhood ofthe aggregates.
Typical areas of sections at 2 and 12 months respectively are shown in Fig. 9
and 10.
DISCUSSION
In the earlier experiment (Guimaraes, Lamerton and Christensen, 1955)
histological studies were made only onthorotrast-injected mice, which died orwere
sacrificed thirteen to twenty-one months after injection. In these animals one
malignant reticulo-endothelioma in the liver and five hepatomas were found, at
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least one malignant haemangio-endothelioma in the spleen and seven lung
adenomas. The present study, extending over a shorter time (maximum of
twelve months) showed clearly that the incidence of neoplasms is greater in
injected than in control animals. The malignant neoplasia observed, two
reticulo-endotheliomas, both occurred in injected animals. Ofthe non-malignant
neoplasia five hepatomas and eight lung adenomas were found in the injected
animals, while in the control animals two hepatomas and four lung adenomas
were found. No malignant haemangio-endotheliomas in the spleen were observed
in the present series, but this may have been because of the shorter duration of
the experiment, since in the previous study the only certain tumour of this type
was found in the animal sacrificed twenty months after injection.
The present study has given no indication that tissue destruction of any sort
precedes the development ofthe liver neoplasia even although the radiation dosage
is very large. The development of the malignant reticulo-endotheliomas can be
traced back to a directly induced reticulo-endothelial proliferation, as shown in
Fig. 1, 2(a), 2(b), 3(a) and 3(b). This proliferation leads to a disruption of the
sinusoid wall, with oedema of the Disse spaces and blood extravasation later.
Liver cells in this area show atrophy and regressive changes. The reticulo-
endothelioma overgrowth then steadily and progressively replaces the liver
parenchyma. Although the mouse reticulo-endotheliomas appear to belong to
the same basic cellular type as those described by Johansen (1955) in his thoro-
trast treated rabbits, they do not show vascular formation and they apparently
arise in the liver, disseminating in later stages, whereas in the rabbits they appear
to be of a multifocal origin.
In the case of the hepatomas in the injected mice, not only was there an
absence of preceding tissue destruction, but there was no apparent relationship
between the intensity of the degenerative cell changes and the incidence of the
hepatomas.
The alveolar cell proliferation in the lung preceding tumour formation was.
again seen in the present series, but the granulomatous reaction reported by
Johansen (1955) in rabbits was not observed.
A number of lines of experimental work have suggested that the carcinogenic
effect of radiation can be interpreted as a form of reaction to gross tissue damage
and destruction produced by the radiation. There was, however, no evidence of
gross tissue damage in the present study. It may be that certain of the changes
produced by thorotrast can be considered as a speeding up of natural processes,
and it is of interest that some cell changes and moderate reticulo-endothelial
proliferation were seen in two of the control animals killed at twelve months. It
is not known to what extent malignant reticulo-endothelioma will appear
spontaneously in this strain of mice at a later stage, and this is intended as the
subject of a future study.
The carcinogenic effect ofthorotrast may, of course, be related to some extent
to the physical presence oftheparticulate material inthe tissue or even to chemical
properties of thorium. These are aspects of the problem which so far have
received no serious study, but must be investigated before any mechanism of the
action of thorotrast can be put forward with confidence.
The present study gives clear evidence of the increase in average size of
thorotrast aggregates from 1 month up to at least 12 months, when the last
group of mice was sacrificed.
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SUMMARY
In continuation of a previous investigation (Guimaraes, Lamerton and
Christensen, 1955) a histological study has been made of the tissues of thorotrast
injected and control mice sacrificed at intervals up to one year. It appears that
the development of reticulo-endotheliomas of the liver is not the consequence of
any gross tissue destruction and repair, but follows a generalised reticulo-
endothelial proliferation. In the case ofthe hepatomas appearing in the injected
mice there was also no evidence of preceding tissue destruction.
This study has also given evidence of the increase with time in the mean size
of thorotrast aggregates in liver tissue.
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